Company

Cutting-edge Japanese stem cell technology for a brighter future

Alfresa Group

We aim to become a healthcare consortium
that provides products and services
across every area of healthcare.

The Alfresa Group is a leader
in Japan’s healthcare industry,
engaged in a wide range of businesses
including the distribution of specialty and general pharmaceuticals, pharmaceutical manufacturing,

the operation of compounding pharmacies,
and regenerative
medicine–related services.

JENECELL, the Korean subsidiary of Alfresa Corporation,
the pharmaceutical arm of the Alfresa Group,

develops innovative biosolutions using stem cell and
culture media technologies.

We Create and
Deliver a Fresh Life for All.

Our Promise

Alfresa Group